2107 Stock Overview
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Shandong Wohua Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.42 |
| 52 Week High | CN¥7.22 |
| 52 Week Low | CN¥3.20 |
| Beta | 0.31 |
| 1 Month Change | -9.24% |
| 3 Month Change | -21.63% |
| 1 Year Change | -30.61% |
| 3 Year Change | -42.37% |
| 5 Year Change | -9.57% |
| Change since IPO | 47.82% |
Recent News & Updates
Shareholder Returns
| 2107 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 3.3% | 3.0% | 1.6% |
| 1Y | -30.6% | -12.9% | -15.1% |
Return vs Industry: 002107 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 002107 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 2107 volatility | |
|---|---|
| 2107 Average Weekly Movement | 9.6% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 002107's share price has been volatile over the past 3 months.
Volatility Over Time: 002107's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 1,353 | Yingzi Zeng | www.wohua.cn |
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers tablets, hard capsules, granules, powders, and pills, such as honeyed, water, and concentrated pills. The company also produces and sells oral liquids, mixtures, liquors, tinctures, decoctions, and syrups, as well as patent medicines; and provides medical technology consulting services.
Shandong Wohua Pharmaceutical Co., Ltd. Fundamentals Summary
| 2107 fundamental statistics | |
|---|---|
| Market cap | CN¥2.51b |
| Earnings (TTM) | CN¥58.77m |
| Revenue (TTM) | CN¥909.51m |
43.4x
P/E Ratio2.8x
P/S RatioIs 2107 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2107 income statement (TTM) | |
|---|---|
| Revenue | CN¥909.51m |
| Cost of Revenue | CN¥234.75m |
| Gross Profit | CN¥674.76m |
| Other Expenses | CN¥615.99m |
| Earnings | CN¥58.77m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 74.19% |
| Net Profit Margin | 6.46% |
| Debt/Equity Ratio | 0% |
How did 2107 perform over the long term?
See historical performance and comparison